Background illustration for clinical trials search

Paid Clinical Trials Nashville

Discover 1,248 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

The Ailliance Post-Market Clinical Study

for
Spinal Deformity, Spinal Degenerative Disorder,
Location: Nashville TN, Louisville KY, Bloomington IN,
Sponsor: Medtronic Spinal and Biologics

Sex: All

Age: 18+

Code: NCT05856370

Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Nashville TN, Jeffersonville IN, Cincinnati OH,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase2, Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,
Location: Nashville TN, Jeffersonville IN, Germantown TN,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase2, Recruiting

PSMA PET Combined With MRI for the Detection of PCa

for
PCA, Prostate Cancer, Prostatic Neoplasm, PSMA PET,
Location: Nashville TN, Germantown TN, Indianapolis IN,
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited

Sex: Male

Age: 18+

Code: NCT07052214

Phase3, Recruiting

Pompe Disease Registry Protocol

for
Glycogen Storage Disease Type II, Pompe Disease
Location: Nashville TN, Birmingham AL, Decatur GA, Cincinnati OH,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00231400

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Nashville TN, Birmingham AL, Atlanta GA, Durham NC,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07206225

Phase1, Recruiting

Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

for
Low Grade Upper Tract Urothelial Carcinoma
Location: Nashville TN, Jeffersonville IN, Atlanta GA,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT07265947

Phase2, Recruiting

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

for
NMIBC
Location: Nashville TN, Atlanta GA, Troy MI, Cynwyd PA,
Sponsor: ImmunityBio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06800963

Phase1, Phase2, Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

for
Non-Muscle Invasive Bladder Cancer
Location: Nashville TN, Knoxville TN, Germantown TN, St Louis MO,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06319820

Phase3, Recruiting

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

for
Prostate Cancer, Prostatic Neoplasms
Location: Nashville TN, Birmingham AL, Indianapolis IN,
Sponsor: Clarity Pharmaceuticals Ltd

Sex: Male

Age: 18+

Code: NCT06056830

Phase3, Recruiting

Patient Retrospective Outcomes (PRO)

for
Chronic Pain
Location: Murfreesboro TN, Cincinnati OH, Greenville SC,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT01550575

Recruiting

Fabry Disease Registry & Pregnancy Sub-registry

for
Fabry Disease
Location: Nashville TN, Birmingham AL, Decatur GA, Cincinnati OH,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00196742

Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG,
Location: Nashville TN, Greenwood IN, Gahanna OH, Chicago IL,
Sponsor: Theralase® Technologies Inc.

Sex: All

Age: 18+

Code: NCT03945162

Phase2, Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Nashville TN, Jeffersonville IN, Germantown TN,
Sponsor: CG Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06567743

Phase2, Recruiting

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

for
Prostate Cancer,
Location: Nashville TN, Jeffersonville IN, Durham NC,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male

Age: 18+

Code: NCT04729114

Phase1, Recruiting

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Nashville TN, Germantown TN, Atlanta GA, Cincinnati OH,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06545955

Phase3, Recruiting

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Nashville TN, Homewood AL, Memphis TN, St Louis MO,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT05951179

Phase2, Recruiting

The OBSERVE Protocol

for
Major Depression Disorder
Location: Nashville TN, Atlanta GA, Bellaire TX, Milford CT,
Sponsor: Yale University

Sex: All

Age: 0+

Code: NCT06725277

Recruiting

Mechanically Optimizing Cardiac Preload in Heart Failure Patients

for
Heart Failure
Location: Nashville TN
Sponsor: Cardioflow Technologies, LLC

Sex: All

Age: 18 - 70+

Code: NCT04338503

Recruiting

PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study

for
Depression
Location: Nashville TN, Atlanta GA, Bellaire TX, Milford CT,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06713616

Phase3, Recruiting